Adiponectin, an adipose tissue-derived insulin sensitizer, is a key component of the interrelationship between adiposity and insulin resistance and is a significant risk factor for T2D (Silva et al., 2014). This evidence concerns the gene ADIPOQ and Insulin resistance.